Similar articles

• [Hematopoietic stem cell transplantation for multiple myeloma].

  Kanda Y. Kanda Y. Rinsho Ketsueki. 2009 Oct;50(10):1420-6. Rinsho Ketsueki. 2009. PMID: 19915350 Review. Japanese. No abstract available.
• Treatment of multiple myeloma in the targeted therapy era.

  Saad AA, Sharma M, Higa GM. Saad AA, et al. Ann Pharmacother. 2009 Feb;43(2):329-38. doi: 10.1345/aph.1L428. Epub 2009 Feb 3. Ann Pharmacother. 2009. PMID: 19193585 Review.
• Treatment of multiple myeloma: 2009 update.

  [No authors listed] [No authors listed] Prescrire Int. 2009 Dec;18(104):263-6. Prescrire Int. 2009. PMID: 20025098
• [Chemotherapy for multiple myeloma].

  Ishida T. Ishida T. Nihon Rinsho. 2007 Dec;65(12):2280-4. Nihon Rinsho. 2007. PMID: 18069273 Review. Japanese.
• DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma.

  Lemaire O, Attal M, Bourin P, Laroche M. Lemaire O, et al. Eur J Haematol. 2010 Mar;84(3):276-7. doi: 10.1111/j.1600-0609.2009.01372.x. Epub 2009 Nov 5. Eur J Haematol. 2010. PMID: 19891699 No abstract available.